Simris Group AB (PUBL) (SIMRIS-B.ST)
Stockholm · SEK · Healthcare · Biotechnology
SEK 0.1195 (-1.65%) as of
Key statistics
- Market cap
- 161.30M
- EPS (TTM)
- -0.0300
- Dividend yield
- 0.00%
- 52-week range
- 0.0402 – 0.1950
- Beta
- 0.88
- Revenue (TTM)
- 1.39M
- Profit margin
- 0.00%
- Volume
- 30.99k
About Simris Group AB (PUBL)
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Hammenhög, Sweden
- Employees
- 5
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.